✦ LIBER ✦

The addition of metformin and glucagon-like peptide-1 receptor agonist or dipeptidyl-peptidase-4 inhibitor to insulin for latent autoimmune diabetes in adults

✍ Scribed by Moriyama, Sumie; Yanai, Hidekatsu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The incretin system: glucagon-like pepti

✍ Daniel J Drucker; Michael A Nauck 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 320 KB

Reshaping Diabetes Care: The Fundamental

✍ Umpierrez, Guillermo; Meneghini, Luigi 📂 Article 📅 2013 🏛 American Association of Clinical Endocrinologists 🌐 English ⚖ 510 KB

Incretin-based Therapies (Glucagon-like

✍ Amir Hanna; Vincent Woo; Jean-François Yale; Elaine M. Cooke 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 208 KB

Glycaemic efficacy of glucagon-like pept

✍ C. F. Deacon; E. Mannucci; B. Ahrén 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 559 KB

Efficacy and safety of the glucagon-like

✍ Van Gaal, Luc; Souhami, Elisabeth; Zhou, Tianyue; Aronson, Ronnie 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 657 KB